Recursion Pharmaceuticals

RXRX

Last Price

12/20/24, 09:30 AM
 EDT
$
6.03
(
+
-1.0
%)

Margin of Safety

+
8.3
%
6.53
NASDAQ

Stock charts are coming!

Solt DB launched with awesome written research, bottom-up modeling, and Margin of Safety signals.

Interactive stock charts are the very next thing we're working on site-wide. Our stock charts will have additional data layers, such as flags for events, modeling refinements, and research notes; as well as historical modeled fair valuation.

Want to request new features? Don't like the position or look of something? Let us know -- we'll add or change it: invest@soltdb.com

Last Price

$
6.03

Margin of Safety

+
8.3
%

Est. Fair ValuE (PER share)

$
6.53

Portfolio Category

Growth (Speculative)
RXRX

EST. Fair ValuE (PER share)

$
6.53

EST. Fair ValuE (MKT Cap)

$1.927 billion

Current Model Basis

Existing Pipeline, Tech Stack, and Data Services

Last Refinement

August 8, 2024

Portfolio Category

Growth (Speculative)

Allocation Suggestion

Up to 5%

Research Deep Dive

Last Updated:

Overview

Solt DB Invest will introduce Base Research for our coverage ecosystem over the next month to coincide with third-quarter 2023 earnings announcements. Check back soon!

Technology Platform

Pipeline

Portfolio

Opportunities & Advantages

Challenges & Risks

Development Risk 

Regulatory Risk 

Commercial Risk 

Dilution Risk 

Valuation Risk 

Geopolitical Risk 

Unique Risks 

Modeling Insights

News Flow & Timing